Table 3.
TCM Symptomsa.
Interview 2 (Day 7 ± 1) |
Interview 3 (Day 14 ± 2) |
|||||||
---|---|---|---|---|---|---|---|---|
Treatment (n = 36) | Placebo (n = 36) | P | Treatment (n = 36) | Placebo (n = 36) | P | |||
Palpitation | Decrease | 8 (23.5%) | 5 (15.1%) | .794 | Decrease | 8 (26.7%) | 4 (15.4%) | .253 |
No change | 22 (64.7%) | 26 (78.8%) | No change | 19 (63.3%) | 18 (69.2%) | |||
Increase | 4 (11.7%) | 2 (6.1%) | Increase | 3 (10.0%) | 4 (15.4%) | |||
P | .378 | .359 | P | .237 | 1.000 | |||
Chest distress | Decrease | 12 (35.3%) | 7 (21.2%) | .311 | Decrease | 17 (56.7%) | 6 (23.1%) | .015 |
No change | 18 (52.9%) | 22 (66.7%) | No change | 11 (36.7%) | 17 (65.4%) | |||
Increase | 4 (11.8%) | 4 (12.1%) | Increase | 2 (6.7%) | 3 (11.5%) | |||
P | .077 | .549 | P | .003 | .508 | |||
Fullness and distention | Decrease | 16 (47.1%) | 3 (9.1%) | .006 | Decrease | 15 (50.0%) | 4 (15.4%) | .013 |
No change | 15 (44.1%) | 28 (84.8%) | No change | 12 (40.0%) | 17 (65.4%) | |||
Increase | 3 (8.8%) | 2 (6.1%) | Increase | 3 (10.0%) | 5 (19.2%) | |||
P | .057 | 1.000 | P | .042 | 1.000 | |||
Shortness of breath | Decrease | 16 (47.1%) | 6 (18.2%) | .019 | Decrease | 16 (53.3%) | 7 (26.9%) | .031 |
No change | 16 (47.1%) | 24 (72.7%) | No change | 13 (43.3%) | 17 (65.4%) | |||
Increase | 2 (5.8%) | 3 (9.1%) | Increase | 1 (3.3%) | 2 (7.7%) | |||
P | .006 | .508 | P | <.001 | .180 | |||
Pain | Decrease | 0 | 1 (3.0%) | .431 | Decrease | 7 (23.3%) | 6 (23.1%) | .732 |
No change | 26 (76.5%) | 26 (78.8%) | No change | 22 (73.3%) | 18 (69.2%) | |||
Increase | 8 (23.5%) | 6 (18.2%) | Increase | 1 (3.3%) | 2 (7.7%) | |||
P | .008 | .125 | P | .063 | .289 |
Abbreviation: TCM, traditional Chinese medicine.
Comparison between groups: Wilcoxon rank-sum test. Comparison in group: Wilcoxon signed rank test.